Diagnostic and prognostic impact of nuclear cardiology in the management of acute coronary syndromes and acute myocardial infarction

Imaging Decisions MRI

Volumn 8, Issue 3, 2004, Pages 9-16

  Pirich, Christian ^a   Graf, S ^b   Behesthi, M ^b  

^a UNIVERSITY OF SALZBURG   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Infarction; Ischaemia; Myocardium; Perfusion; Scintigraphy

Indexed keywords

FLUORODEOXYGLUCOSE F 18; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; TETROFOSMIN TC 99M; THALLIUM 201;

ACUTE HEART INFARCTION; ARTICLE; CONTRAST ENHANCEMENT; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE PERFUSION; HUMAN; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; SCINTIANGIOCARDIOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 11144254083     PISSN: 14333317     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1617-0830.2004.00026.x     Document Type: Article

References (68)

1. Hofstra L, Liem IH, Dumont EA et al. Visualisation of cell death in vivo in patients with acute myocardial infarction. Lancet 2000; 356: 209-212.
2. Granato JE, Watson DD, Flanagan TL et al. Myocardial thallium-201 kinetics during coronary occlusion and reperfusion: influence of method of reflow and timing of thallium-201 administration. Circulation 1986; 73: 150-160.
3. DeCoster PM, Wijns W, Cauwe F et al. Area-at-risk determination by technetium-99m-hexakis-2-methoxyisobutyl isonitrile in experimental reperfused myocardial infarction. Circulation 1990; 82: 2152-2162.
4. Sinusas AJ, Trautman KA, Bergin JD et al. Quantification of area at risk during coronary occlusion and degree of myocardial salvage after reperfusion with technetium-99m methoxyisobutyl isonitrile. Circulation 1990; 82: 1424-1437.
5. Varetto T, Cantalupi D, Altieri A et al. Emergency room Tc-99m sestamibi imaging to rule out acute myocardial ischemic events in patients with nondiagnostic electrocardiography. J Am Coll Cardiol 1993; 22: 1804-1808.
6. Hilton TC, Thompson RC, Williams H et al. Tc-99m sestamibi myocardial perfusion imaging in the emergency room evaluation of chest pain. J Am Coll Cardiol 1994; 23: 1016-1022.
7. Kontos MC, Jesse RL, Schmidt KL et al. Value of acute rest sestamibi perfusion imaging for evaluation of patients admitted to the emergency department with chest pain. J Am Coll Cardiol 1997; 30: 976-982.
8. Heller GV, Stowers SA, Hendel RC et al. Clinical value of acute rest technetium-99m tetrofosmin tomographic myocardial perfusion imaging in patients with acute chest pain and nondiagnostic electrocardiograms. J Am Coll Cardiol 1998; 31: 1011-1017.
9. Cerqueira MD, Maynard C, Ritchie JL et al. Long-term survival in 618 patients from the Western Washington streptokinase in myocardial infarction trials. J Am Coll Cardiol 1992; 20: 1452-1459.
10. Miller TD, Christian TF, Hopfenspirger F et al. Infarct size after acute myocardial infarction measured by quantitative tomography Tc-99m sestamibi imaging predicts subsequent mortality. Circulation 1995; 92: 334-341.
11. Gibbons RJ, Holmes DR, Reeder GS et al. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. N Engl J Med 1993; 328: 685-691.
12. Gibbons RJ, Verani MS, Behrenbeck T et al. Feasibility of tomographic 99mTc-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging for the assessment of myocardial area at risk and the effect of treatment in acute myocardial infarction. Circulation 1989; 80: 1277-1286.
13. Santoro GM, Bisi G, Sciagra R et al. Single photon emission computed tomography with technetium-99m hexakis 2-methoxyisobutyl isonitrile in acute myocardial infarction before and after thrombolytic treatment: assessment of salvaged myocardium and prediction of late functional recovery. J Am Coll Cardiol 1990; 15: 301-314.
14. Dixon SR, Whitbourn RJ, Dae MW et al. Induction of mild systemic hypothermia with endovascular cooling during primary percutaneous coronary intervention for acute myocardial infarction. J Am Coll Cardiol 2002; 40: 928-1934.
15. Kopecky SL, Aviles RJ, Bell MR et al. AmP579 Delivery for Myocardial Infarction REduction study. A randomized, double-blinded, placebo-controlled, dose-ranging study measuring the effect of an adenosine agonist on infarct size reduction in patients undergoing primary percutaneous transluminal coronary angioplasty: the ADMIRE (AmP579 Delivery for Myocardial Infarction REduction) study. Am Heart J 2003; 146: 146-152.
16. Angeja BG, Gunda M, Murphy SA et al. TIMI myocardial perfusion grade and ST segment resolution: association with infarct size as assessed by single photon emission computed tomography imaging. Circulation 2002; 105: 282-285.
17. Faxon DP, Gibbons RJ, Chronos NA, Gurbel PA, Sheehan F, HALT-MI Investigators. The effect of blockade of the CD11/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty: the results of the HALT-MI study. J Am Coll Cardiol 2002; 40: 1199-1204.
18. Verani MS, Gaeta J, LeBlanc AD et al. Validation of left ventricular volume measurements by radionuclide angiography. J Nucl Med 1985; 26: 1394-1401.
19. Mahmarian JJ, Moye L, Verani MS et al. Criteria for the accurate interpretation of changes in left ventricular ejection fraction and cardiac volumes as assessed by rest and exercise gated radionuclide angiography. J Am Coll Cardiol 1991; 18: 112-119.
20. The Multicenter Postinfarction Research Group. Risk stratification and survival after myocardial infarction. N Engl J Med 1983; 309: 331-336.
21. Dakik HA, Mahmarian JJ, Kimball KT et al. Prognostic value of exercise thallium-201 tomography in patients treated with thrombolytic therapy during acute myocardial infarction. Circulation 1996; 94: 2735-2742.
22. White HD, Norris RM, Brown MA et al. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 1987; 76: 44-51.
23. Seals AA, Pratt CM, Mahmarian JJ et al. Relation of left ventricular dilation during acute myocardial infarction to systolic performance, diastolic dysfunction, infarct size and location. Am J Cardiol 1988; 61: 224-229.
24. Pfeffer MA, Lamas GA, Vaughan DE, Parisi AF, Braunwald E. Effect of captopril on progressive left ventricular dilation after anterior myocardial infarction. N Engl J Med 1988; 319: 8096.
25. Mahmarian JJ, Moye LA, Chinoy DA et al. Transdermal nitroglycrin patch therapy improves left ventricular function and prevents remodeling after acute myocardial infarction: results of a multicenter prospective randomized double-blind placebo controlled trial. Circulation 1998; 97: 2017-2024.
26. Candell-Riera J, Permanyer-Miralda G, Castell J et al. Uncomplicated first myocardial infarction: strategy for comprehensive prognostic studies. J Am Coll Cardiol 1991; 18: 1207-1219.
27. Abraham RD, Harris PJ, Roubin GS et al. Usefulness of ejection fraction response to exercise one month after acute myocardial infarction in predicting coronary anatomy and prognosis. Am J Cardiol 1987; 60: 225-230.
28. Corbett JR, Dehmer GJ, Lewis SE et al. The prognostic value of submaximal exercise testing with radionuclide ventriculography before hospital discharge in patients with recent myocardial infarction. Circulation 1981; 64: 535-544.
29. Nicod P, Corbett JR, Firth BG et al. Prognostic value of resting and submaximal exercise radionuclide ventriculography after acute myocardial infarction in high-risk patients with single and multivessel disease. Am J Cardiol 1983; 52: 30-36.
30. Roig E, Magrina J, Armengol X et al. Prognostic value of exercise radionuclide angiography in low-risk acute myocardial infarction survivors. Eur Heart J 1993; 14: 213-218.
31. Zaret BL, Wackers FJ, Terrin ML et al. Value of radionuclide rest and exercise left ventricular ejection fraction in assessing survival of patients after thrombolytic therapy for acute myocardial infarction: results of Thrombolysis in Myocardial Infarction (TIMI) phase II study. The TIMI Study Group. J Am Coll Cardiol 1995; 26: 73-79.
32. Theroux P, Waters DD, Halphen C et al. Prognostic value of exercise testing soon after myocardial infarction. N Engl J Med 1979; 301: 341-345.
33. Weld FM, Chu KL, Bigger JT, Roinitzky LM. Risk stratification with low-level exercise testing 2 weeks after acute myocardial infarction. Circulation 1981; 64: 306-314.
34. Gibson RS, Watson DD, Craddock GB et al. Prediction of cardiac events after uncomplicated myocardial infarction: a prospective study comparing predischarge exercise thallium-201 scintigraphy and coronary angiography. Circulation 1983; 68: 321-336.
35. Wilson WW, Gibson RS, Nygaard TW et al. Acute myocardial infarction associated with single vessel coronary artery disease. An analysis of clinical outcome and the prognostic importance of vessel patency and residual ischemic myocardium. J Am Coll Cardiol 1988; 11: 223-234.
36. Brown KA, Weiss RM, Clements JP et al. Usefulness of residual ischemic myocardium within prior infarct zone for identifying patients at high risk late after acute myocardial infarction. Am J Cardiol 1987; 60: 15-19.
37. Travin MI, Dessouki A, Cameron T, Heller GV. Use of exercise technetium-99m sestamibi SPECT imaging to detect residual ischemia and for risk stratification after acute myocardial infarction. Am J Cardiol 1995; 75: 665-669.
38. Wilson RF, Wyche K, Christensen BV, Zimmer S, Laxson DD. Effects of adenosine on human coronary arterial circulation. Circulation 1990; 82: 1595-1606.
39. Rossen JD, Quillen JE, Lopez AG et al. Comparison of coronary vasodilation with intravenous dipyridamole and adenosine. J Am Coll Cardiol 1991; 18: 485-491.
40. Heller GV, Ahmed I, Tilkemeier PL et al. Influence of exercise intensity on the presence, distribution, and size of thallium-201 defects. Am Heart J 1992; 123: 909-916.
41. Heller GV, Brown KA, Landin RJ, Haber SB. Safety of early intravenous dipyridamole technetium 99m sestamibi SPECT myocardial perfusion imaging after uncomplicated first myocardial infarction. Early Post MI IV Dipyridamole Study (EPIDS). Am Heart J 1997; 134: 105-111.
42. Mahmarian JJ, Pratt CM, Nishimura S et al. Quantitative adenosine TI-201 single-photon emission computed tomography for the early assessment of patients surviving acute myocardial infarction. Circulation 1993; 87: 1197-1210.
43. Abreu A, Mahmarian JJ, Nishimura S, Boyce TM, Verani MS. Tolerance and safety of pharmacologic coronary vasodilation with adenosine in association with thallium-201 scintigraphy in patients with suspected coronary artery disease. J Am Coll Cardiol 1991; 18: 730-735.
44. Brown KA, O'Meara J, Chambers CE et al. Ability of dipyridamolethallium- 201 imaging 1 to 4 days after acute myocardial infarction to predict in-hospital and late recurrent myocardial ischemic events. Am J Cardiol 1990; 65: 160-167.
45. Leppo JA, O'Brien J, Rothendler JA et al. Dipyridamole-thallium-201 scintigraphy in the prediction of future cardiac events after acute myocardial infarction. N Engl J Med 1984; 310: 1014-1018.
46. Gimple LW, Hutter AM, Guiney TE Jr, Boucher CA. Prognostic utility of predischarge dipyridamole-thallium imaging after uncomplicated acute myocardial infarction. Am J Cardiol 1989; 64: 1243-1248.
47. Chiamvimonvat V, Goodman SG, Langer A, Barr A, Freeman MR. Prognostic value of dipyridamole SPECT imaging in low-risk patients after myocardial infarction. J Nucl Cardiol 2001; 8: 136-143.
48. Brown KA, Heller GV, Landin RS et al. Early dipyridamole 99mTc-sestamibi single photon emission computed tomographic imaging 2 to 4 days after acute myocardial infarction predicts in-hospital and postdischarge cardiac events: comparison with submaximal exercise imaging. Circulation 1999; 100: 2060-2066.
49. Mahmarian JJ, Mahmarian AC, Marks GF, Pratt CM, Verani MS. Role of adenosine thallium-201 tomography for defining long-term risk in patients after acute myocardial infarction. J Am Coll Cardiol 1995; 25: 1333-1340.
50. Zellweger MJ, Dubois EA, Lai S et al. Risk stratification in patients with remote prior myocardial infarction using rest-stress myocardial perfusion SPECT: prognostic value and impact on referral to early catheterization. J Nucl Cardiol 2002; 9: 23-32.
51. Terrin ML, Williams DO, Kleiman NS et al. Two- and three-year results of the Thrombolysis in Myocardial Infarction (TIMI) phase II clinical trial. J Am Coll Cardiol 1993; 22: 1763-1772.
52. Chairman BR, McMahon RP, Terrin M et al. Impact of treatment strategy on predischarge exercise test in the Thrombolysis in Myocardial Infarction (TIMI) II trial. Am J Cardiol 1993; 71: 131-138.
53. Tilkemeier PL, Guiney TE, LaRaia PJ, Boucher CA. Prognostic value of predischarge low-level exercise thallium testing after thrombolytic treatment of acute myocardial infarction. Am J Cardiol 1990; 66: 1203-1207.
54. Haber HL, Beller GA, Watson DD, Gimple LW. Exercise thallium-201 scintigraphy after thrombolytic therapy with or without angioplasty for acute myocardial infarction. Am J Cardiol 1993; 71: 1257-1261.
55. Williams DO, Braunwald E, Knatterud G et al. One-year results of the Thrombolysis in Myocardial Infarction Investigation (TIMI) phase II trial. Circulation 1992; 85: 533-542.
56. Udelson JE, Beshansky JR, Ballin DS et al. Myocardial perfusion imaging for evaluation and triage of patients with suspected acute cardiac ischemia: a randomized controlled trial. JAMA 2002; 288: 2693-2700.
57. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003; 361: 13-20.
58. TIMI Study Group, Gibson CM, Karha J, Murphy SA et al. Early and long-term clinical outcomes associated with reinfarction following fibrinolytic administration in the Thrombolysis in Myocardial Infarction trials. J Am Coll Cardiol 2003; 42: 7-16.
59. Fragmin and Fast Revascularisation during InStability in Coronary artery disease (FRISC II) Investigators. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. Lancet 1999; 354: 708-715.
60. TACTICS-Thrombolysis in Myocardial Infarction 18 Investigators, Cannon CP, Weintraub WS, Demopoulos LA et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001; 344: 1879-1887.
61. Ndrepepa G, Mehilli J, Schwaiger M et al. Prognostic value of myocardial salvage achieved by reperfusion therapy in patients with acute myocardial infarction. J Nucl Med 2004; 45: 725-729.
62. Mahmarian JJ, Fenimore NL, Marks GF et al. Transdermal nitroglycerin patch therapy reduces the extent of exercise-induced myocardial ischemia: results of a double-blind, placebo-controlled trial using quantitative thallium-201 tomography. J Am Coll Cardiol 1994; 24: 25-32.
63. Lewin HC, Hachamovitch R, Harris HG et al. Sustained reduction of exercise perfusion defect extent and severity with isosorbide mononitrate (Imdur) as demonstrated by means of technetium 99m sestamibi. J Nucl Cardiol 2000; 7: 342-353.
64. Sharir T, Rabinowitz B, Livschitz S et al. Underestimation of extent and severity of coronary artery disease by dipyridamole stress thallium-201 single-photon emission computed tomographic myocardial perfusion imaging in patients taking antianginal drugs. J Am Coll Cardiol 1998; 31: 1540-1546.
65. Schwartz RG, Pearson TA, Kalaria VG et al. Prospective serial evaluation of myocardial perfusion and lipids during the first six months of pravastatin therapy: coronary artery disease regression single photon emission computed tomography monitoring trial. J Am Coll Cardiol 2003; 42: 600-610.
66. Dakik HA, Kleiman NS, Farmer JA et al. Intensive medical therapy versus coronary angioplasty for suppression of myocardial ischemia in survivors of acute myocardial infarction. A prospective, randomized pilot study. Circulation 1998; 98: 2017-2023.
67. Angiogenic GENe Therapy (AGENT-2) Study Group, Grines CL, Watkins MW, Mahmarian JJ et al. A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina. J Am Coll Cardiol 2003; 42: 1339-1347.
68. Boden WE, O'Rourke RA, Crawford MH et al. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators. N Engl J Med 1998; 338: 1785-1792.